Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny– Hagens Berman SNPS Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted […]
New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public. SO WHAT:
(NASDAQ:TLX), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA
(NASDAQ:DXCM), RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025,
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter — Hagens Berman TLX Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire November 24, 2025 RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against
(NYSE:KMX), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from
CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending — Hagens Berman KMX Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet
McCann Systemsis pleased to be crowned the winner of the 2025 Make a Difference Award.This award, co-presented by Commercial Integrator and ADI, recognizes integrators whose philanthropic efforts and charitable contributions create a lasting impact on communities and people in need. https://mma.prnewswire.com/media/2202151/McCann_Systems__logo.jpg Commercial Integrator and ADI's Make a Difference Awardcelebrates organizations that go beyond day-to-day operations
The Tribunal issued an Order in the above-named matter. A copy of the Order dated November 24, 2025 is available at capitalmarketstribunal.ca Registrar, Governance & Tribunal SecretariatOntario Securities Commission Subscribe to notices and other alerts from the Capital Markets Tribunal:https://www.capitalmarketstribunal.ca/en/news/subscribe SOURCE Ontario Securities Commission https://rt.newswire.ca/rt.gif?NewsItemId=C6304&Transmission_Id=202511241511CANADANWWEB______C6304&DateId=20251124